ORIC FY 2024 Earnings — ORIC Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

ORICORIC Pharmaceuticals, Inc.

$1B

FY 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$1M

Operating Income

-$143M

Net Income

-$128M

EPS (Diluted)

$-1.83

Cash Flow

Operating Cash Flow

-$113M

Free Cash Flow

-$114M

Stock-Based Comp.

$20M

Balance Sheet

Total Assets

$274M

Total Liabilities

$31M

Stockholders' Equity

$243M

Cash & Equivalents

$59M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$1M	-$1M	-7.3%
Operating Income	-$143M	-$111M	-29.0%
Net Income	-$128M	-$101M	-27.0%